Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CNTY-101 |
Synonyms | |
Therapy Description |
CNTY-101 are iPSC-derived CAR-NK cells that have been engineered to express IL-15 and a chimeric antigen receptor (CAR) targeting CD19, which potentially results in tumor cell killing and inhibition of tumor growth (Blood (2021) 138 (Supplement 1): 1729). |